GL-PD
GL-PD
Globe Life Inc. 4.25% Junior SuIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.52B ▲ | $106.35M ▼ | $266M ▼ | 17.45% ▼ | $3.35 ▼ | $379.27M ▼ |
| Q3-2025 | $1.51B ▲ | $147.7M ▲ | $387.84M ▲ | 25.63% ▲ | $4.81 ▲ | $513.24M ▲ |
| Q2-2025 | $1.48B ▲ | $143.18M ▼ | $252.75M ▼ | 17.06% ▼ | $3.09 ▲ | $348.18M ▼ |
| Q1-2025 | $1.48B ▲ | $143.74M ▼ | $254.56M ▼ | 17.2% ▼ | $3.05 ▲ | $351.07M ▲ |
| Q4-2024 | $1.47B | $155.01M | $255.2M | 17.4% | $3.04 | $348.13M |
What's going well?
Revenue is stable and the company remains solidly profitable. Operating expenses were cut, showing some cost discipline.
What's concerning?
Gross margins fell hard, and profits dropped by nearly a third. Rising product costs are a big risk if not brought under control.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $459.42M ▼ | $30.81B ▲ | $24.84B ▲ | $5.97B ▲ |
| Q3-2025 | $18.16B ▲ | $30.53B ▲ | $24.84B ▲ | $5.69B ▲ |
| Q2-2025 | $17.72B ▼ | $29.81B ▲ | $24.39B ▲ | $5.42B ▼ |
| Q1-2025 | $17.87B ▲ | $29.71B ▲ | $24.28B ▲ | $5.43B ▲ |
| Q4-2024 | $17.41B | $29.08B | $23.77B | $5.31B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $266.08M ▲ | $350.6M ▲ | $-265.84M ▼ | $-241.01M ▼ | $-158.01M ▼ | $330.1M ▲ |
| Q3-2025 | $0 | $305.98M ▼ | $-73.79M ▼ | $-171.79M ▲ | $63.59M ▲ | $208.69M ▼ |
| Q2-2025 | $0 ▼ | $307.93M ▼ | $-64.03M ▲ | $-230.78M ▼ | $6.85M ▼ | $294.99M ▼ |
| Q1-2025 | $254.56M ▼ | $431.89M ▲ | $-239.95M ▼ | $-124.46M ▲ | $66.94M ▲ | $420.14M ▲ |
| Q4-2024 | $255.2M | $336.93M | $181.37M | $-500.95M | $30.78M | $321.93M |
What's strong about this company's cash flow?
The company consistently produces more cash than it spends, with operating and free cash flow both rising. It returns most excess cash to shareholders through large buybacks, and doesn't rely on debt or outside funding.
What are the cash flow concerns?
The cash balance is shrinking, dropping by $158 million this quarter, which could become a problem if this trend continues. There is also no dividend, and the company has little margin for error if cash outflows stay high.
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Health Segment | $370.00M ▲ | $380.00M ▲ | $390.00M ▲ | $390.00M ▲ |
Life Segment | $830.00M ▲ | $840.00M ▲ | $840.00M ▲ | $850.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Globe Life Inc. 4.25% Junior Su's financial evolution and strategic trajectory over the past five years.
GL-PD’s underlying issuer, Globe Life, shows a combination of steady revenue growth, strong and stable profitability, and very robust free cash flow. The balance sheet is supported by growing retained earnings and improving liquidity, while the business itself benefits from a defensible niche, entrenched distribution channels, and simple, recurring-premium products. Together, these features contribute to a financial profile that has historically been resilient and supportive of its various capital instruments, including junior subordinated securities.
Key risks include a clear upward trend in leverage, with rising debt and interest costs, and aggressive capital returns to common shareholders that increase pressure on the balance sheet. Some data gaps and anomalies reduce transparency around the most recent year’s cost structure and certain balance-sheet items. Competitively, Globe Life faces threats from large insurers, digital-native entrants, and changing customer expectations, as well as the usual regulatory and economic risks that affect life insurers. For a junior instrument like GL-PD, these factors matter because they influence the issuer’s long-term capacity to meet all obligations across the capital structure.
Based on the information provided, Globe Life appears to be a mature, cash-generative insurer with a stable core franchise, gradually adapting to a more digital world while leaning more heavily on debt and buybacks to manage its capital structure. If it can maintain its strong cash generation, keep underwriting disciplined, and pace its leverage carefully, the overall financial profile should remain solid. The main variables to monitor over time are the balance between shareholder returns and balance-sheet strength, the trajectory of operating cash flows, and the company’s success in updating its distribution and technology to sustain its competitive edge.
About Globe Life Inc. 4.25% Junior Su
https://www.globelifeinsurance.comGlobe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $1.52B ▲ | $106.35M ▼ | $266M ▼ | 17.45% ▼ | $3.35 ▼ | $379.27M ▼ |
| Q3-2025 | $1.51B ▲ | $147.7M ▲ | $387.84M ▲ | 25.63% ▲ | $4.81 ▲ | $513.24M ▲ |
| Q2-2025 | $1.48B ▲ | $143.18M ▼ | $252.75M ▼ | 17.06% ▼ | $3.09 ▲ | $348.18M ▼ |
| Q1-2025 | $1.48B ▲ | $143.74M ▼ | $254.56M ▼ | 17.2% ▼ | $3.05 ▲ | $351.07M ▲ |
| Q4-2024 | $1.47B | $155.01M | $255.2M | 17.4% | $3.04 | $348.13M |
What's going well?
Revenue is stable and the company remains solidly profitable. Operating expenses were cut, showing some cost discipline.
What's concerning?
Gross margins fell hard, and profits dropped by nearly a third. Rising product costs are a big risk if not brought under control.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $459.42M ▼ | $30.81B ▲ | $24.84B ▲ | $5.97B ▲ |
| Q3-2025 | $18.16B ▲ | $30.53B ▲ | $24.84B ▲ | $5.69B ▲ |
| Q2-2025 | $17.72B ▼ | $29.81B ▲ | $24.39B ▲ | $5.42B ▼ |
| Q1-2025 | $17.87B ▲ | $29.71B ▲ | $24.28B ▲ | $5.43B ▲ |
| Q4-2024 | $17.41B | $29.08B | $23.77B | $5.31B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $266.08M ▲ | $350.6M ▲ | $-265.84M ▼ | $-241.01M ▼ | $-158.01M ▼ | $330.1M ▲ |
| Q3-2025 | $0 | $305.98M ▼ | $-73.79M ▼ | $-171.79M ▲ | $63.59M ▲ | $208.69M ▼ |
| Q2-2025 | $0 ▼ | $307.93M ▼ | $-64.03M ▲ | $-230.78M ▼ | $6.85M ▼ | $294.99M ▼ |
| Q1-2025 | $254.56M ▼ | $431.89M ▲ | $-239.95M ▼ | $-124.46M ▲ | $66.94M ▲ | $420.14M ▲ |
| Q4-2024 | $255.2M | $336.93M | $181.37M | $-500.95M | $30.78M | $321.93M |
What's strong about this company's cash flow?
The company consistently produces more cash than it spends, with operating and free cash flow both rising. It returns most excess cash to shareholders through large buybacks, and doesn't rely on debt or outside funding.
What are the cash flow concerns?
The cash balance is shrinking, dropping by $158 million this quarter, which could become a problem if this trend continues. There is also no dividend, and the company has little margin for error if cash outflows stay high.
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Health Segment | $370.00M ▲ | $380.00M ▲ | $390.00M ▲ | $390.00M ▲ |
Life Segment | $830.00M ▲ | $840.00M ▲ | $840.00M ▲ | $850.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Globe Life Inc. 4.25% Junior Su's financial evolution and strategic trajectory over the past five years.
GL-PD’s underlying issuer, Globe Life, shows a combination of steady revenue growth, strong and stable profitability, and very robust free cash flow. The balance sheet is supported by growing retained earnings and improving liquidity, while the business itself benefits from a defensible niche, entrenched distribution channels, and simple, recurring-premium products. Together, these features contribute to a financial profile that has historically been resilient and supportive of its various capital instruments, including junior subordinated securities.
Key risks include a clear upward trend in leverage, with rising debt and interest costs, and aggressive capital returns to common shareholders that increase pressure on the balance sheet. Some data gaps and anomalies reduce transparency around the most recent year’s cost structure and certain balance-sheet items. Competitively, Globe Life faces threats from large insurers, digital-native entrants, and changing customer expectations, as well as the usual regulatory and economic risks that affect life insurers. For a junior instrument like GL-PD, these factors matter because they influence the issuer’s long-term capacity to meet all obligations across the capital structure.
Based on the information provided, Globe Life appears to be a mature, cash-generative insurer with a stable core franchise, gradually adapting to a more digital world while leaning more heavily on debt and buybacks to manage its capital structure. If it can maintain its strong cash generation, keep underwriting disciplined, and pace its leverage carefully, the overall financial profile should remain solid. The main variables to monitor over time are the balance between shareholder returns and balance-sheet strength, the trajectory of operating cash flows, and the company’s success in updating its distribution and technology to sustain its competitive edge.

CEO
Frank Martin Svoboda
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 8
Ratings Snapshot
Rating : A-

